ICON Executive and Leadership Team

Deepali Suri, the President, ICON Biotech at ICON, manages the strategic direction of biotechnology service offerings. Overseeing the expansion of specialized research capabilities, the President, ICON Biotech ensures that emerging biotech firms receive tailored support for complex drug development programs. This leadership role involves coordinating cross-functional teams to navigate regulatory landscapes and accelerate time-to-market for innovative therapies. By optimizing operational workflows within the biotech division, Deepali Suri directly impacts the success of early-stage clinical trials and commercialization efforts. The President, ICON Biotech collaborates with global stakeholders to identify market opportunities and enhance service delivery across North American and European regions. Through the application of deep industry expertise, Suri fosters strong partnerships with clients, ensuring that the organization remains a preferred partner for high-growth biotechnology ventures seeking to translate scientific breakthroughs into viable medical solutions for diverse patient populations.

Connie Inguanti, the President, Symphony Health at ICON, leads the data-driven analytics and market intelligence division. Overseeing the synthesis of real-world evidence and patient data, the President, Symphony Health ensures that pharmaceutical clients gain actionable insights for commercialization strategies. This leadership role involves managing large-scale data assets to support evidence-based decision-making in the healthcare industry. By refining the analytical frameworks used to evaluate drug performance and market access, Connie Inguanti directly impacts the strategic planning of global health organizations. The President, Symphony Health coordinates with internal research teams to translate complex datasets into clear, actionable business intelligence. Through the continuous improvement of data processing capabilities, Inguanti strengthens the market position of the firm, enabling clients to navigate the complexities of the modern healthcare landscape with precision and confidence while maintaining rigorous standards for data privacy and regulatory compliance.

Thomas Marsland, the President at ICON, oversees the overarching operational execution and corporate growth initiatives. Directing the alignment of diverse business units, the President ensures that the organization maintains its status as a leader in drug and device development services. This leadership role involves managing high-level client relationships and steering the company toward long-term financial stability. By optimizing resource allocation across global operations, Thomas Marsland directly impacts the scalability of clinical research services. The President collaborates with the Board to define the strategic vision and ensure that all departments contribute to the mission of advancing public health. Through the implementation of rigorous performance metrics, Marsland drives operational excellence and fosters a culture of accountability. This executive leadership role remains central to the firm's ability to navigate the competitive landscape of the global pharmaceutical services industry while delivering consistent value to stakeholders and clients.

James Alloco, the Chief Technology Officer at ICON, directs the digital transformation of clinical research platforms. Overseeing the integration of advanced data analytics and cloud-based infrastructure, the Chief Technology Officer ensures that pharmaceutical and biotechnology clients receive high-fidelity insights during drug development cycles. This leadership role involves architecting scalable software solutions that streamline complex trial processes across global markets. By modernizing the technological backbone of the organization, James Alloco directly impacts the efficiency of medical device testing and commercialization workflows. The Chief Technology Officer maintains alignment with the broader corporate strategy by prioritizing cybersecurity and data integrity. Through the implementation of cutting-edge digital tools, Alloco secures the competitive advantage of the firm in the rapidly evolving life sciences sector, ultimately driving innovation in clinical research methodologies and supporting the delivery of life-saving therapies to patients worldwide.

Marian Colon-Nieves, the Manager, Clinical Operations & Chief People Officer at ICON, directs the intersection of human capital strategy and clinical trial execution. Overseeing the recruitment and development of specialized talent, the Manager, Clinical Operations & Chief People Officer ensures that the organization possesses the expertise required for complex medical device and drug development projects. This leadership role involves fostering an inclusive corporate culture that supports high-performance teams across international regions. By aligning workforce capabilities with the operational demands of clinical research, Marian Colon-Nieves directly impacts the quality and speed of trial delivery. The Manager, Clinical Operations & Chief People Officer coordinates with department heads to streamline internal processes and enhance employee engagement. Through the strategic management of human resources and operational workflows, Colon-Nieves strengthens the organizational capacity to meet the evolving needs of the global biotechnology and pharmaceutical sectors.